The estimated Net Worth of Chad Winters is at least $1.04 million dollars as of 11 March 2024. Mr. Winters owns over 815 units of West Pharmaceutical Services stock worth over $395,474 and over the last 5 years he sold WST stock worth over $645,975. In addition, he makes $0 as Chief Accounting Officer, Principal Accounting Officer, Vice President et Controller at West Pharmaceutical Services.
Chad has made over 3 trades of the West Pharmaceutical Services stock since 2023, according to the Form 4 filled with the SEC. Most recently he sold 815 units of WST stock worth $292,438 on 11 March 2024.
The largest trade he's ever made was exercising 1,744 units of West Pharmaceutical Services stock on 30 May 2023 worth over $421,124. On average, Chad trades about 223 units every 18 days since 2020. As of 11 March 2024 he still owns at least 1,308 units of West Pharmaceutical Services stock.
You can see the complete history of Mr. Winters stock trades at the bottom of the page.
Chad R. Winters serves as Chief Accounting Officer, Principal Accounting Officer, Vice President, Controller of the Company. He `was appointed our Vice President and Corporate Controller in October 2019, with responsibility for the accounting, U.S. Securities and Exchange Commission (“SEC”) reporting, and financial operations functions of the Company. He joined the Company from Amneal Pharmaceuticals, Inc., and its predecessors, where he most recently served as Senior Vice President of Finance & Accounting and Controller. Prior to that, Mr. Winters held roles of increasing responsibility at The Chemours Company, UGI Corporation and PricewaterhouseCoopers LLP. Mr. Winters holds a Bachelor of Science degree from Villanova University and is a Certified Public Accountant.
Chad Winters is 42, he's been the Chief Accounting Officer, Principal Accounting Officer, Vice President et Controller of West Pharmaceutical Services since 2020. There are 26 older and no younger executives at West Pharmaceutical Services. The oldest executive at West Pharmaceutical Services, Inc. is Patrick Zenner, 73, who is the Independent Chairman of the Board.
Chad's mailing address filed with the SEC is , 530 HERMAN O. WEST DRIVE, EXTON, PA, 19341.
Over the last 19 years, insiders at West Pharmaceutical Services have traded over $32,829,857 worth of West Pharmaceutical Services stock and bought 19,924 units worth $1,139,950 . The most active insiders traders include Robert F Friel, Paolo Pucci et Douglas A Michels. On average, West Pharmaceutical Services executives and independent directors trade stock every 40 days with the average trade being worth of $4,786,805. The most recent stock trade was executed by Charles Witherspoon on 19 August 2024, trading 1,029 units of WST stock currently worth $308,700.
west works side-by-side with healthcare partners from concept to the patient, designing and manufacturing packaging and delivery systems that promote efficiency, reliability and safety. west leads the way with cutting-edge technologies and quality systems, a thorough understanding of global regulatory compliance, and an unmatched knowledge of relevant pharmaceutical product testing, development and packaging. west supports customers from sales, manufacturing, and research and development locations in north and south america, europe, asia and australia.
West Pharmaceutical Services executives and other stock owners filed with the SEC include: